AAVR disruption as a producer-cell engineering strategy for enhanced supernatant-based recovery of selected AAV serotypes

Molecular Therapy Advances · Elsevier

Аннотация

Publication date: 10 September 2026 Source: Molecular Therapy Advances, Volume 34, Issue 3 Author(s): Kenji Sakamoto, Kouhei Yoshida, Yuji Tsunekawa, Naymel A. Guzman Mendoza, Yui Komaki, Azusa Onodera, Takashi Okada

Читать у издателя →

Похожие статьи